Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Replimune Group, Inc. Director's Dealing 2023

Jun 5, 2023

33193_dirs_2023-06-05_cb0522fa-2ba6-4e5d-81ee-f681e0de8805.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2023-06-01

Reporting Person: Peeples-Dyer Veleka (Director)

More from Replimune Group, Inc.

Director's Dealing 2026
Feb 20
Major Shareholding Notification 2026
Feb 17
Regulatory Filings 2026
Feb 3
Interim / Quarterly Report 2026
Feb 3
Regulatory Filings 2026
Jan 12
Director's Dealing 2025
Dec 19
Director's Dealing 2025
Dec 19
Director's Dealing 2025
Dec 19
Director's Dealing 2025
Dec 19
Director's Dealing 2025
Dec 19
View all filings →